Biotechnology major on Thursday said its unit has received approval from the US health regulator to market a generic product. Biocon Pharma, a subsidiary of the company, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolic Acid, the company …
Read More »Gland Pharma gets tentative nod from USFDA for generic Sugammadex injection
Drug firm Gland Pharma on Friday said it has received a tentative nod from the US health regulator for generic Sugammadex injection, which is indicated for reversing the effects of the muscle relaxants rocuronium bromide and vecuronium bromide given to patients during surgery. The company “has received tentative approval from …
Read More »Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil
Pharma, a wholly owned subsidiary of Biocon, has partnered with Brazil’s Libbs Farmaceutica to launch generic drugs in the South American country. This partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab …
Read More »